NCT05977751View on ClinicalTrials.gov

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

NARecruitingINTERVENTIONAL
Enrollment

573

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

December 31, 2029

Study Completion Date

June 30, 2031

Conditions
Contraception
Interventions
DEVICE

FemBloc

Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes.

Trial Locations (6)

31909

RECRUITING

Midtown OB GYN North, Columbus

45242

RECRUITING

Seven Hills Women's Health Centers, Cincinnati

84108

RECRUITING

University of Utah, Salt Lake City

94304

RECRUITING

Stanford University, Palo Alto

95817

RECRUITING

University of California Davis, Sacramento

11219-2919

RECRUITING

Maimonides Medical Center, Brooklyn

Sponsors

Lead Sponsor

Femasys Inc.
All Listed Sponsors
lead

Femasys Inc.

INDUSTRY

NCT05977751 - Prospective Multi-Center Trial for FemBloc Permanent Birth Control | Biotech Hunter | Biotech Hunter